We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$910M
AUM Growth
+$13.7M
Cap. Flow
-$4.92M
Cap. Flow %
-0.54%
Top 10 Hldgs %
28.47%
Holding
182
New
5
Increased
48
Reduced
80
Closed
6

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$5.75M
2
CB icon
Chubb
CB
+$3.59M
3
DOX icon
Amdocs
DOX
+$2.87M
4
WPP icon
WPP
WPP
+$1.94M
5
PPG icon
PPG Industries
PPG
+$1.58M

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$13.7M
2
COL
Rockwell Collins
COL
+$3.13M
3
XRAY icon
Dentsply Sirona
XRAY
+$2.83M
4
MSFT icon
Microsoft
MSFT
+$1.62M
5
AMAT icon
Applied Materials
AMAT
+$776K

Sector Composition

Rank Sector Weight
1 Technology 23.14%
2 Healthcare 16.72%
3 Financials 10.76%
4 Consumer Staples 10.3%
5 Industrials 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHW
101
Charles Schwab
SCHW
$184B
$873K 0.1%
17,092
-1,050
-6% -$58.2K
NBL
102
DELISTED
Noble Energy, Inc.
NBL
$873K 0.1%
24,749
-100
-0.4% -$3.4K
BA icon
103
Boeing
BA
$175B
$813K 0.09%
2,423
-90
-4% -$31K
RDS.A
104
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$771K 0.08%
11,139
– –
NBIX icon
105
Neurocrine Biosciences
NBIX
$18.4B
$755K 0.08%
7,685
+40
+0.5% +$3.58K
FAST icon
106
Fastenal
FAST
$55.2B
$753K 0.08%
62,540
– –
ABBV icon
107
AbbVie
ABBV
$465B
$746K 0.08%
8,054
-1,173
-13% -$115K
WFC icon
108
Wells Fargo
WFC
$263B
$741K 0.08%
13,360
+108
+0.8% +$5.79K
ISRG icon
109
Intuitive Surgical
ISRG
$130B
$740K 0.08%
4,638
-195
-4% -$29.7K
SGEN
110
DELISTED
Seagen Inc. Common Stock
SGEN
$735K 0.08%
11,076
+70
+0.6% +$4.01K
CHX
111
DELISTED
ChampionX
CHX
$693K 0.08%
+16,608
New +$680K
V icon
112
Visa
V
$697B
$692K 0.08%
5,226
-481
-8% -$61.9K
SLB icon
113
SLB Ltd
SLB
$74.2B
$684K 0.08%
10,198
– –
GLD icon
114
SPDR Gold Trust
GLD
$131B
$680K 0.07%
5,727
+727
+15% +$90K
MO icon
115
Altria Group
MO
$125B
$656K 0.07%
11,554
-1,209
-9% -$69.7K
FUL icon
116
H.B. Fuller
FUL
$3.07B
$649K 0.07%
12,094
– –
BMRN icon
117
BioMarin Pharmaceuticals
BMRN
$12B
$621K 0.07%
6,592
+45
+0.7% +$3.94K
CSX icon
118
CSX Corp
CSX
$94.2B
$587K 0.06%
27,600
-300
-1% -$6.18K
VEU icon
119
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$570K 0.06%
11,000
+2,050
+23% +$111K
AMZN icon
120
Amazon
AMZN
$2.48T
$569K 0.06%
6,700
-420
-6% -$33.3K
IONS icon
121
Ionis Pharmaceuticals
IONS
$9.14B
$561K 0.06%
13,469
+80
+0.6% +$3.55K
LLY icon
122
Eli Lilly
LLY
$1.09T
$548K 0.06%
6,425
+92
+1% +$7.56K
OMC icon
123
Omnicom Group
OMC
$24.6B
$542K 0.06%
7,111
– –
INCY icon
124
Incyte
INCY
$26B
$529K 0.06%
7,893
+70
+0.9% +$4.79K
FISV
125
Fiserv Inc
FISV
$28.9B
$522K 0.06%
7,048
-454
-6% -$33K
3 4
5
6 7

Similar funds

HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return

Grandfield & Dodd's Q2 2018 Portfolio in Review

As of Q2 2018, Grandfield & Dodd held 182 positions worth $910M, up 1.5% from $896M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Grandfield & Dodd's Q2 2018 filing shows 5 new, 48 increased, 80 reduced and 6 closed positions. Its largest new stake was Amdocs: 42,700 shares worth $2.83M. The largest sale was Time Warner Inc, an estimated $13.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q2 2018 buy was Amdocs: 42,700 shares worth $2.83M.
  • Grandfield & Dodd added most to AT&T in Q2 2018, an estimated $5.75M increase.
  • Grandfield & Dodd's biggest Q2 2018 reduction was Rockwell Collins, cutting an estimated $3.13M.
  • Grandfield & Dodd fully exited Time Warner Inc in Q2 2018, selling an estimated $13.7M.
  • Grandfield & Dodd's ten largest holdings make up 28% of its $910M portfolio in Q2 2018.
  • Grandfield & Dodd opened 5 new positions and closed 6 in Q2 2018.
  • Grandfield & Dodd's portfolio value rose 1.5% quarter-over-quarter to $910M.

Based on Grandfield & Dodd's 13F filing for Q2 2018, filed 27 Jul 2018.